IMU Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - ImmunoGen Inc

Watchlist Manager

Watchlist

Price: 28.88 EUR Market Closed

Market Cap: €1.4B

I	ImmunoGen Inc DUS:IMU	US
	Next PLC LSE:NXT	UK
A	Airbus SE XMUN:AIR	NL
D	Dominion Energy Inc F:DOD	US
N	Novo Nordisk A/S XMUN:NOVA	DK

Profitability Summary

ImmunoGen Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

99%

Strong 3Y Average Gross Margin

95%

Gross Margin is Increasing

75% > 99%

Negative Operating Margin

-28%

Negative 3Y Average Operating Margin

-62%

Operating Margin is Increasing

-199% > -28%

Negative Net Margin

-26%

Negative 3Y Average Net Margin

-61%

Net Margin is Increasing

-199% > -26%

Negative Free Cash Flow Margin

-69%

Negative 3Y Average Free Cash Flow Margin

-105%

Free Cash Flow Margin is Increasing

-218% > -69%

Negative ROE

-20%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-157%

ROIC is Increasing

-582% > -74%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.